JP2021527129A5 - - Google Patents
Info
- Publication number
- JP2021527129A5 JP2021527129A5 JP2021518057A JP2021518057A JP2021527129A5 JP 2021527129 A5 JP2021527129 A5 JP 2021527129A5 JP 2021518057 A JP2021518057 A JP 2021518057A JP 2021518057 A JP2021518057 A JP 2021518057A JP 2021527129 A5 JP2021527129 A5 JP 2021527129A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- product according
- pharmaceutical product
- administration
- pharmaceutical
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862682794P | 2018-06-08 | 2018-06-08 | |
| US62/682,794 | 2018-06-08 | ||
| PCT/US2019/036139 WO2019237054A1 (en) | 2018-06-08 | 2019-06-07 | Methods and compositions for preventing or treating calciphylaxis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527129A JP2021527129A (ja) | 2021-10-11 |
| JPWO2019237054A5 JPWO2019237054A5 (https=) | 2022-06-10 |
| JP2021527129A5 true JP2021527129A5 (https=) | 2022-06-10 |
Family
ID=68763971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518057A Pending JP2021527129A (ja) | 2018-06-08 | 2019-06-07 | カルシフィラキシスを予防または治療するための方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (7) | US10736858B2 (https=) |
| EP (1) | EP3801478A4 (https=) |
| JP (1) | JP2021527129A (https=) |
| KR (1) | KR20210018422A (https=) |
| CN (1) | CN112955131A (https=) |
| AU (1) | AU2019282421B2 (https=) |
| CA (1) | CA3102979A1 (https=) |
| IL (1) | IL279246B2 (https=) |
| MX (2) | MX2020013301A (https=) |
| SG (1) | SG11202012055PA (https=) |
| WO (1) | WO2019237054A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| MX2020013302A (es) | 2018-06-08 | 2021-05-12 | Epizon Pharma Inc | Métodos y composiciones para prevenir o tratar calcificación de tejido. |
| US10822295B2 (en) | 2018-09-12 | 2020-11-03 | Epizon Pharma, Inc. | Menaquinol compositions and methods of treatment |
| EP3890831A4 (en) * | 2019-01-04 | 2022-09-21 | Kaydence Pharma AS | COMBINATION THERAPY OF PHOSPHATE BINDERS AND VITAMIN K |
| CN112691058A (zh) * | 2020-12-31 | 2021-04-23 | 玉溪健坤生物药业有限公司 | 一种含还原型维生素k2的牙膏及其制备方法 |
| CN114748486A (zh) * | 2022-03-25 | 2022-07-15 | 南京盛德生物科技研究院有限公司 | 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050176778A1 (en) | 2001-08-03 | 2005-08-11 | Vitak Bv | Isoprenyl derivatives and their use in the title treatment and prevention of osteoporosis and cardiovascular calcification |
| WO2005030190A1 (en) | 2003-09-26 | 2005-04-07 | Natural Asa | Natural menaquinone 7 compositions |
| DE602006020658D1 (de) | 2005-06-03 | 2011-04-28 | Nattopharma Asa | Verwendung von Vitamin K, um die Verkalkung der Blutgefässe rückgängig zu machen |
| WO2007095630A2 (en) | 2006-02-15 | 2007-08-23 | The Regents Of The University Of California | New ubiquinone analogs and methods of use |
| NZ574882A (en) * | 2006-07-14 | 2012-08-31 | Nattopharma Asa | Pharmaceutical and nutraceutical products comprising vitamin k2 |
| GB0817528D0 (en) | 2008-09-24 | 2008-10-29 | Syntavit As | Process |
| BR112013009724A2 (pt) | 2010-11-01 | 2016-07-19 | Viridis Biopharma Pvt Ltd | equilíbrio dinâmico do sistemna nervoso autonômo utilizando a vitamina mk-7 |
| GB201203705D0 (en) | 2012-03-02 | 2012-04-18 | Kappa Bioscience As | Prodrugs |
| US10159787B2 (en) | 2012-06-18 | 2018-12-25 | Fresenius Kabi Deutschland Gmbh | Port cannula system for puncturing port catheters |
| WO2014191466A1 (en) | 2013-05-28 | 2014-12-04 | Nattopharma Asa | Menaquinone supplementation and vascular health |
| GB201314245D0 (en) | 2013-08-08 | 2013-09-25 | Kappa Bioscience As | Provitamins |
| EP2868658B1 (en) | 2013-11-01 | 2018-05-02 | Dilip Mehta | Method of preparation of stereospecific quinone derivatives |
| EP3258924A2 (en) * | 2015-02-20 | 2017-12-27 | VitaK B.V. | Vitamin k and capillary function |
| BR112017019750A2 (en) | 2015-03-20 | 2018-05-29 | Gnosis S.P.A. | process for preparing a crystalline form of menaquinol, crystalline form of menaquinol, process for preparing a solid form of menaquinol, pharmaceutical or nutraceutical composition and use of the crystalline form of menaquinol |
| CN206387961U (zh) | 2016-12-30 | 2017-08-08 | 孙淑芬 | 头戴显示设备 |
| IT201700085412A1 (it) * | 2017-07-26 | 2019-01-26 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
| US10368858B1 (en) | 2018-01-25 | 2019-08-06 | Ring Orthopedics, Inc. | Suture passer |
| EP3774707A1 (en) | 2018-04-06 | 2021-02-17 | Instytut Farmaceutyczny | Process of vitamin k 2 derivatives preparation |
| MX2020013302A (es) | 2018-06-08 | 2021-05-12 | Epizon Pharma Inc | Métodos y composiciones para prevenir o tratar calcificación de tejido. |
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| US10822295B2 (en) | 2018-09-12 | 2020-11-03 | Epizon Pharma, Inc. | Menaquinol compositions and methods of treatment |
-
2019
- 2019-06-07 WO PCT/US2019/036139 patent/WO2019237054A1/en not_active Ceased
- 2019-06-07 EP EP19814419.8A patent/EP3801478A4/en active Pending
- 2019-06-07 JP JP2021518057A patent/JP2021527129A/ja active Pending
- 2019-06-07 AU AU2019282421A patent/AU2019282421B2/en active Active
- 2019-06-07 CA CA3102979A patent/CA3102979A1/en active Pending
- 2019-06-07 MX MX2020013301A patent/MX2020013301A/es unknown
- 2019-06-07 US US16/435,230 patent/US10736858B2/en active Active
- 2019-06-07 CN CN201980052691.0A patent/CN112955131A/zh active Pending
- 2019-06-07 KR KR1020217000119A patent/KR20210018422A/ko active Pending
- 2019-06-07 SG SG11202012055PA patent/SG11202012055PA/en unknown
-
2020
- 2020-06-16 US US16/902,705 patent/US11065212B2/en active Active
- 2020-06-16 US US16/902,709 patent/US10987320B2/en active Active
- 2020-06-16 US US16/902,701 patent/US10925838B2/en active Active
- 2020-07-31 US US16/944,479 patent/US10940123B2/en active Active
- 2020-12-06 IL IL279246A patent/IL279246B2/en unknown
- 2020-12-07 MX MX2024010211A patent/MX2024010211A/es unknown
-
2021
- 2021-06-16 US US17/349,663 patent/US11793773B2/en active Active
-
2023
- 2023-08-07 US US18/231,035 patent/US12433854B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527129A5 (https=) | ||
| JP2021527128A5 (https=) | ||
| Boojar et al. | Overview of Silibinin anti-tumor effects | |
| Andújar et al. | Shikonin promotes intestinal wound healing in vitro via induction of TGF-β release in IEC-18 cells | |
| JP7525868B2 (ja) | アルカリ性化剤による血液浄化 | |
| CN101217952A (zh) | 用于预防心血管事件发病的组合物 | |
| CN113038940A (zh) | 用于预防或治疗组织钙化的方法和组合物 | |
| KR20240040767A (ko) | His 저감반응자의 치료 | |
| JPWO2019237054A5 (https=) | ||
| JPWO2019237053A5 (https=) | ||
| JP2008280333A (ja) | 末期癌等治療用医薬組成物 | |
| JP2018516931A5 (https=) | ||
| JP6207560B2 (ja) | 膵炎を治療するためのゲムカベンおよび誘導体 | |
| JP2019513802A (ja) | 組み合わせ組成物およびその使用方法 | |
| CN104095843A (zh) | 牛蒡子苷元在制备治疗消化道溃疡性疾病药物中的应用 | |
| RU2447913C1 (ru) | Способ лечения местнораспространенного рака молочной железы с опухолевыми изъязвлениями кожи | |
| Yahya et al. | Old drug with new milestone: chloroquine and hydroxychloroquine in SARS-COV-2 (COVID-19) with multifaceted effects in other diseases | |
| JP6184960B2 (ja) | メラトニンの新規用途 | |
| CN105434459A (zh) | 一种治疗溃疡的西药配方及其制备工艺 | |
| EP3969110A1 (en) | Compositions comprising 15-hepe and/or 15-hetre and methods of treating or preventing cardiometabolic disease, metabolic syndrome, and/or related diseases | |
| ROCHA et al. | Functional nutrition in postoperative plastic surgery: focus on seroma and fibrosis prevention | |
| HINT | FICA: Taking a Spiritual History | |
| CN101766618A (zh) | 匹伐他汀钙的新用途以及针对新用途的药物 | |
| WO2017180259A1 (en) | Methods for treating nsaid-induced cardiovascular, cerebrovascular, or renovascular adverse events | |
| JPWO2006011495A1 (ja) | 高コレステロール血症及び／又は高トリグリセリド血症治療剤 |